Category: Ocrevus

OCREVUS (OCRELIZUMAB) DATA SHOW EARLY INITIATION OF TREATMENT REDUCES DISABILITY PROGRESSION OVER FIVE YEARS IN RELAPSING AND PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS

October 10, 2018 People with relapsing MS (RMS) treated sooner with OCREVUS had earlier reduction in disease activity and less…

Stuart Schlossman

Genentech to Present Five-Year OCREVUS (Ocrelizumab) Efficacy and Safety Data in Relapsing and Primary Progressive Multiple Sclerosis at ECTRIMS

Monday, Oct 1, 2018 Genentech to Present Five-Year OCREVUS (Ocrelizumab) Efficacy and Safety Data in Relapsing and Primary Progressive Multiple…

Stuart Schlossman

Ocrelizumab: A Review in Multiple Sclerosis

Syed YY. CNS Drugs. 2018. Authors Syed YY1. Author information 1 Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New…

Stuart Schlossman

#AAN2018 — Ocrevus Lowers Immune Response to Vaccines in Relapsing MS, Phase 3 Trial Shows

Treatment with Ocrevus (ocrelizumab) is linked to a reduced immune response to vaccinations in patients with relapsing multiple sclerosis (MS), according to a Phase…

Stuart Schlossman

The History of Ocrevus’ – The Journey from Defiant Idea to Game-Changing Treatment

Information found below was acquired from MS NewsToday Link Twenty years ago, the idea that B-cell depletion could treat multiple…

Stuart Schlossman

Ocrelizumab More Cost-Effective Than Interferon

J Med Econ; 2017 Oct; Yang, Duchesneau, et al November 21, 2017 Ocrelizumab is more cost-effective than subcutaneous (SC) interferon…

Stuart Schlossman

New OCREVUS (Ocrelizumab) Data at ECTRIMS Advance Clinical Understanding of Underlying Progression in Multiple Sclerosis

·       Data show superiority of OCREVUS compared to Rebif (interferon beta-1a) in significantly reducing disability Progression Independent of Relapse Activity…

Stuart Schlossman

Ocrelizumab Offers Greater Value Than Interferon

J Med Econ; 2017 Oct; Frasco, Shih, Incerti, et al October 17, 2017 Ocrelizumab provides greater value to relapsing forms…

Stuart Schlossman

UCSF Neurologist Played Key Role in MS Research Turning to B-Cells, Essential Step to Ocrevus

                                       …

Stuart Schlossman

Ocrevus Phase 3 Trial Will Explore How Treatment Works by Viewing Changes in Spinal Fluid

                                       …

Stuart Schlossman

Categories

Latest Blog Posts